Brian Park, PharmD

Drug Information Specialist https://www.empr.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Drugs in the Pipeline

Dasiglucagon Reduces Glucose Requirements in Congenital Hyperinsulinism Trial

Brian Park, PharmD

May 19, 2022

The phase 3 trial evaluated dasiglucagon administered as a continuous IV infusion via a pump in 12 children with persistent CHI.

Drugs in the Pipeline

Tasquinimod Gets Orphan Drug Designation for Myelofibrosis

Brian Park, PharmD

May 18, 2022

Tasquinimod is an investigational oral small molecule immune modulator with anti-angiogenic properties.

News

Labcorp Provides HbA1c Testing With At-Home Collection Kit

Brian Park, PharmD

May 18, 2022

The test includes the Weavr Velvet blood collection device, which separates the sample into its red blood cell and plasma components.

Drugs in the Pipeline

FDA Declines EUA Request for Fluvoxamine for COVID-19 Treatment

Brian Park, PharmD

May 18, 2022

The totality of the evidence led the FDA to determine that the criteria for issuing an EUA had not been met.

News

FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV

Brian Park, PharmD

May 17, 2022

The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.

News

Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for 5- to 11-Year-Olds

Brian Park, PharmD

May 17, 2022

The Pfizer-BioNTech COVID-19 vaccine can be administered as a single booster dose to individuals 5 to 11 years of age at least 5 months after completion of the primary series.